BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34737082)

  • 1. Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic.
    Eldib AA; Patil P; Nischal KK; Mitchell ER; Hiasat JG; Pihlblad MS
    J AAPOS; 2021 Dec; 25(6):336.e1-336.e4. PubMed ID: 34737082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.
    Chen PL; Hsiao CH; Chen JT; Lu DW; Chen WY
    Am J Ophthalmol; 2006 Sep; 142(3):469-74. PubMed ID: 16935593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of horner syndrome in pediatric patients.
    Chen PL; Chen JT; Lu DW; Chen YC; Hsiao CH
    J Ocul Pharmacol Ther; 2006 Jun; 22(3):182-7. PubMed ID: 16808679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False negative apraclonidine test in two patients with Horner syndrome.
    Kawasaki A; Borruat FX
    Klin Monbl Augenheilkd; 2008 May; 225(5):520-2. PubMed ID: 18454417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apraclonidine for the pharmacologic confirmation of acute Horner syndrome.
    Nguyen MTB; Farahvash A; Zhang A; Micieli JA
    J Neurol Sci; 2020 Dec; 419():117190. PubMed ID: 33075593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis of Horner syndrome using topical apraclonidine.
    Cooper-Knock J; Pepper I; Hodgson T; Sharrack B
    J Neuroophthalmol; 2011 Sep; 31(3):214-6. PubMed ID: 21566530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants.
    Watts P; Satterfield D; Lim MK
    J AAPOS; 2007 Jun; 11(3):282-3. PubMed ID: 17572343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 0.5% apraclonidine on ptosis in Horner syndrome.
    Garibaldi DC; Hindman HB; Grant MP; Iliff NT; Merbs SL
    Ophthalmic Plast Reconstr Surg; 2006; 22(1):53-5. PubMed ID: 16418668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of apraclonidine in the diagnosis of Horner syndrome].
    Pérez-Iñigo MA; González I; Fernández FJ; Díaz S; Ferrer C; Alias E; Honrubia FM
    Arch Soc Esp Oftalmol; 2009 Feb; 84(2):105-8. PubMed ID: 19253181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of digital pupillometry for diagnosis of Horner syndrome.
    Yoo YJ; Yang HK; Hwang JM
    PLoS One; 2017; 12(6):e0178361. PubMed ID: 28575101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients.
    Bacal DA; Levy SR
    Arch Ophthalmol; 2004 Feb; 122(2):276-9. PubMed ID: 14769608
    [No Abstract]   [Full Text] [Related]  

  • 12. Positive Apraclonidine Test in Horner Syndrome Caused by Thalamic Hemorrhage.
    Kauh CY; Bursztyn LL
    J Neuroophthalmol; 2015 Sep; 35(3):287-8. PubMed ID: 25768246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive apraclonidine test 36 hours after acute onset of horner syndrome in dorsolateral pontomedullary stroke.
    Lebas M; Seror J; Debroucker T
    J Neuroophthalmol; 2010 Mar; 30(1):12-7. PubMed ID: 20182200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical apraclonidine to diagnose Bernard-Horner syndrome.
    Kocabora M; Gocmez E; Taskapili M
    Bull Soc Belge Ophtalmol; 2009; (312):9-15. PubMed ID: 19927485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
    Brown SM
    Arch Ophthalmol; 2005 Apr; 123(4):578; author reply 578. PubMed ID: 15824244
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical apraclonidine in the diagnosis of suspected Horner syndrome.
    Freedman KA; Brown SM
    J Neuroophthalmol; 2005 Jun; 25(2):83-5. PubMed ID: 15937427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to topical apraclonidine in children with glaucoma.
    Wright TM; Freedman SF
    J Glaucoma; 2009; 18(5):395-8. PubMed ID: 19525731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome.
    Brown SM; Aouchiche R; Freedman KA
    Arch Ophthalmol; 2003 Aug; 121(8):1201-3. PubMed ID: 12912704
    [No Abstract]   [Full Text] [Related]  

  • 19. Confirmation of Horner's syndrome using apraclonidine eye drops.
    Chu CJ; Ferris JD
    Postgrad Med J; 2011 Jun; 87(1028):440. PubMed ID: 21386103
    [No Abstract]   [Full Text] [Related]  

  • 20. Ocular effects of apraclonidine in Horner syndrome.
    Morales J; Brown SM; Abdul-Rahim AS; Crosson CE
    Arch Ophthalmol; 2000 Jul; 118(7):951-4. PubMed ID: 10900109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.